This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
The US Federal Trade Commission said that CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s Optum illegally steered patients to higher-priced insulins.
Medscape Medical News